Associations of multimorbidity burden with healthcare utilization and expenditures among individuals with diabetes in China
Frontiers in Public Health · 2026
DOI: 10.3389/fpubh.2026.1975609 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, 2026. Verfasst von Jielong Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center of Integrated Chinese and Western Medicine, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen,…. Hauptthemen laut MEDLINE: Multimorbidity, Health Expenditures, Patient Acceptance of Health Care, Diabetes Mellitus. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
Multimorbidity is common among people with diabetes, but its associations with healthcare utilization and medical expenditures in China remain insufficiently characterized. This study aimed to examine these associations using different measures of multimorbidity burden and assess potential sex differences.
Methods
We conducted cross-sectional analyses using the 2018 China Health and Retirement Longitudinal Study (CHARLS) and a retrospective hospital-based cohort. Multimorbidity burden was assessed using four measures: multimorbidity, ≥3 LTCs, number of long-term conditions (LTCs), and the Chinese Multimorbidity-Weighted Index (CMWI). Multivariable regression models were used to examine associations with healthcare utilization and expenditures. Sex-stratified analyses, interaction tests, and sensitivity analyses were also performed.
Results
Among 2,531 CHARLS participants with diabetes, 92.9% had multimorbidity and 77.7% had ≥3 LTCs. All four measures were positively associated with inpatient and outpatient utilization, visit counts, and medical expenditures. The presence of ≥3 LTCs was associated with higher odds of inpatient (OR, 2.44; 95% CI, 1.90–3.16) and outpatient utilization (OR, 2.17; 95% CI, 1.68–2.84), as well as higher total inpatient (cost ratio, 2.98; 95% CI, 1.94–5.24) and outpatient expenditures (cost ratio, 3.15; 95% CI, 1.92–5.72). In the hospital cohort ( n = 3,963), all four measures were positively associated with hospitalization frequency, cumulative inpatient days, and inpatient expenditure. Most sex interaction tests were not statistically significant. Sensitivity analyses yielded generally consistent findings.
Conclusion
Greater multimorbidity burden was associated with higher healthcare utilization and medical expenditures among individuals with diabetes across two different settings. These findings highlight the importance of considering coexisting conditions in healthcare planning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Integrated Chinese and Western Medicine, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.
- Department of Endocrinology, Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China.
- Department of Nephrology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.
Zitieren
APA
Wu, J., Li, B., Wu, X., Hu, X., Zhang, H., Li, Y., Zhang, Z., Cai, M., Piao, C., Zhao, N., & Yang, S. (2026). Associations of multimorbidity burden with healthcare utilization and expenditures among individuals with diabetes in China. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2026.1975609
Vancouver
Wu J, Li B, Wu X, Hu X, Zhang H, Li Y, et al. Associations of multimorbidity burden with healthcare utilization and expenditures among individuals with diabetes in China. Frontiers in Public Health. 2026. doi:10.3389/fpubh.2026.1975609
BibTeX
@article{Wu2026,
author = {Wu, Jielong and Li, Bo and Wu, Xuemin and Hu, Xin and Zhang, Hengyuan and Li, Yiling and Zhang, Zhihai and Cai, Miaona and Piao, Chunli and Zhao, Nengjiang and Yang, Shuyu},
title = {Associations of multimorbidity burden with healthcare utilization and expenditures among individuals with diabetes in China},
journal = {Frontiers in Public Health},
year = {2026},
doi = {10.3389/fpubh.2026.1975609}
}
EUVIMED